PhAST Corp.

PhAST is a Lausanne-based diagnostics company developing rapid single-cell imaging technology for antimicrobial susceptibility testing. Its platform accelerates AST results from days to minutes by imaging individual bacterial cells in real time, enabling clinicians to identify effective antibiotic treatments at the start of care rather than relying on days-long culture-based methods.